Binding and inhibition of myeloperoxidase (MPO): A major function of ceruloplasmin?

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 167-174

  Segelmark, M ^a   Persson, B ^a   Hellmark, T ^a   Wieslander, J ^b  

^a LUND UNIVERSITY   (Sweden)

^b Wieslab AB   (Sweden)

Author keywords

ANCA; Ceruloplasmin; Complement C3d; Glomerulonephritis; Myeloperoxidase

Indexed keywords

AUTOANTIBODY; CERULOPLASMIN; COMPLEMENT COMPONENT C3D; GRANULOCYTE ANTIBODY; MYELOPEROXIDASE;

ADULT; AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0030894460     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-992.x     Document Type: Article

References (30)

1. Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates, 2nd edn. New York: Raven Press, 1992:541-88.
2. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76.
3. Saeki T, Kuroda T, Morita T, Suzuki K, Arakawa M, Kawasaki K. Significance of myeloperoxidase in rapidly progressive glomerulonephritis. Am J Kidney Dis 1995; 26:13-21.
4. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
5. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
6. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41:375-83.
7. Olsson I, Olofsson T, Ohlsson K, Gustavsson A. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia. Scand J Haematol 1979; 22:397-406.
8. Yea CM, Dularay B, Elson CJ. Idenification of a myeloperoxidase inhibitor from normal human serum. Clin Exp Immunol 1991; 84:347-52.
9. Rydén L. Ceruloplasmin. In: Lontie R, ed. Copper proteins and copper enzymes. Boca Raton: CRC Press, Inc., 1984:37-100.
10. Fox PL, Mukhopadyay C, Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci 1995; 56:1749-58.
11. Rydén L, Hunt LT. Evolution of protein complexity: the blue copper-containing oxidases and related proteins. J Mol Evol. 1993; 36:41-66.
12. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GPR. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. QJ Med 1994; 87:663-70.
13. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995; 92:2539-43.
14. Olsson I, Olofsson T, Odeberg H. Myeloperoxidase-mediated iodination in granulocytes. Scand J Haematol 1972; 9:483-91.
15. Segelmark M, Baslund B, Wieslander J. Some patients with anti-MPO have a c-ANCA pattern. Clin Exp Immunol 1994; 96:458-65.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 1970; 227:680-5.
17. Morrisey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117:307-10.
18. Burnett WN. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112:195-203.
19. Johansson C, Butkowski R, Wieslander J. Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 1991; 25:229-41.
20. Hewick RM, Hunkapiller MW, Hood LE, Dryer WJ. A gas-liquid-solid phase peptide and protein sequenator. J Biol Chem 1981; 256:7990-7.
21. Altschul SF, Gish W, Miller W, Meyers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
22. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 2nd edn. Philadelphia: W.B. Saunders Co., 1995.
23. Textbook of clinical chemistry. Philadelphia: W.B. Saunders Co., 1986.
24. Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ. Role of oxidants and proteases in glomerular injury. Kidney Int 1994; 45:352-9.
25. Taylor JC, Oey L. Ceruloplasmin: plasma inhibitor of the oxidative inactivation of alpha1-protease inhibitor. Am Rev Respir Dis 1982; 126:476-82.
26. Brandslund I, Siersted HC, Svehag SE, Teisner B. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products and C3d specificities in plasma. J Immunol Methods 1981; 44:63-71.
27. Tedder TF, Zhou L-J, Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 1994; 15:437-41.
28. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91:1-12.
29. Schultz DR, Tozman EC. Antineutrohil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin Arthritis Rheum 1995; 25:143-59.
30. Segelmark M, Elzouki A-N, Wieslander J, Eriksson S. The PiZ gene of alpha 1 -antitrypsin as a determinant of outcome in PR3-ANCA positive vasculitis. Kidney Int 1995; 48:844-50.